SAB Biotherapeutics reports Q1 2026 results, enrollment progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. SPY
2. MDT
3. DELL
4. USO
5. AAPL
6. SPGI
7. NIO
8. ENOV
9. PANW
10. AON

Go back to SAB Biotherapeutics reports Q1 2026 results, enrollment progress
(NASDAQ: SABS) Delayed: 3.70 -0.01 (0.27%)
Previous Close $3.71    52 Week High $ 
Open $3.65    52 Week Low $ 
Day High $3.75    P/E N/A 
Day Low $3.65    EPS $ 
Volume 202,283       

(NASDAQ: SABSW) Delayed: 0.02 --0 (-0%)
Previous Close $0.02    52 Week High $ 
Open $0.02    52 Week Low $ 
Day High $0.03    P/E N/A 
Day Low $0.02    EPS $ 
Volume 1,407